Liquid biopsy is a minimally invasive blood-based approach that has the potential of providing information on early diagnosis, prognosis, response to therapeutic regimens  and chemo-resistance development. The detection and molecular characterization of circulating tumor cells (CTCs), the detection of circulating tumor DNA (ctDNA), circulating microRNAs (miRNAs) and exosomes, in the peripheral blood of cancer patients, represent the main liquid biopsy approaches.

The aim of the society is the study of biology and clinical significance of CTCs, circulating nucleic acids (ctDNA, circulating miRNAs) and exosomes in the peripheral blood of cancer patients, as long as their interplay with the immune system in different stages of cancer development.    

Contact: hsliquidbiopsy@gmail.com

Find out more about hslb: https://hsliquidbiopsy.wixsite.com/2021